TAK-875 50mg 50mg | Purity Not Available
Adooq Bioscience
TAK-875 is a potent, selective, and orally bioavailable GPR40 agonist.
More Information Supplier PageTAK-875 is a potent, selective, and orally bioavailable GPR40 agonist.
More Information Supplier PageTAK-875 is a potent, selective, and orally bioavailable GPR40 agonist.
More Information Supplier PageTAK-875 is a potent, selective, and orally bioavailable GPR40 agonist.
More Information Supplier PageTAK-875 is a potent, selective, and orally bioavailable GPR40 agonist.
More Information Supplier PageTAK-875 is a potent, selective, and orally bioavailable GPR40 agonist.
More Information Supplier PageLY2157299 is an orally active transforming growth factor beta receptor (TGF-??R) kinase inhibitor.
More Information Supplier PageLY2157299 is an orally active transforming growth factor beta receptor (TGF-??R) kinase inhibitor.
More Information Supplier PageLY2157299 is an orally active transforming growth factor beta receptor (TGF-??R) kinase inhibitor.
More Information Supplier PageLY2157299 is an orally active transforming growth factor beta receptor (TGF-??R) kinase inhibitor.
More Information Supplier PageZM-447439 is a potein, selective ATP-competitive Aurora B kinase inhibitor with an IC50 of 50 nM, 1 ??M and 250 nM for Aurora B, A and C, respectively.
More Information Supplier Page